LeadIQ logo
Learn more at LeadIQ.com
Elicio Therapeutics

Elicio Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Elicio Therapeutics, Inc. (Nasdaq: ELTX) is a clinical-stage biotechnology company advancing a pipeline of novel lymph node-targeted immunotherapies for the treatment of some of the most aggressive cancers. By combining expertise in immunology and immunotherapy, Elicio is harnessing the natural power of the immune system with the Amphiphile (“AMP”) technology, which allows for therapeutic payloads to be delivered directly to the lymph nodes, with the goal of enhancing the immune system’s cancer-fighting capabilities. By targeting cancer immunotherapies to the core of the immune response, AMP aims to optimize the lymph nodes’ natural ability to educate, activate and amplify cancer-specific T cells, which are essential for recognizing and eliminating tumor cells. Engineered to synchronize immunity in these highly potent sites, AMP is built to enhance the magnitude, potency, quality and durability of the immune response to drive antitumor activity. The Company’s R&D pipeline includes off-the-shelf therapeutic cancer vaccines ELI-002, (targeting mKRAS-driven cancers) as well as ELI-007 and ELI-008 (targeting BRAF-driven cancers and p53 hotspot mutations, respectively). For more information, please visit www.elicio.com. 

Find Elicio Therapeutics employees' phone numbers or email addresses

Elicio Therapeutics Global Highlights

Location
Employees

North America
44

Minus sign iconPlus sign icon
  • United States Of America
    44

Europe
3

Minus sign iconPlus sign icon
  • Spain
    1
  • Switzerland
    1
  • United Kingdom Of Great Britain And Northern Ireland
    1

Elicio Therapeutics's Leadership

Elicio Therapeutics Employee Metrics

100%
50%
0%
2024
2023
  • Research
  • Administrative
  • Supply Chain
  • Engineering
  • Finance
  • Other
  • Quality Assurance

Contact profiles from Elicio Therapeutics

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is Elicio Therapeutics known for?

Minus sign iconPlus sign icon
Elicio Therapeutics operates in the Biotechnology Research industry. The company's main headquarters is located in 451 D Street 501 Boston, Massachusetts 02210 US; you can contact the main corporate office by phone at +1-857-209-0056. Explore Elicio Therapeutics's company overview page for more information.

What is Elicio Therapeutics's most common email format?

Minus sign iconPlus sign icon
Elicio Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Elicio Therapeutics email formats with LeadIQ.

How many employees does Elicio Therapeutics have currently?

Minus sign iconPlus sign icon
Elicio Therapeutics has approximately 38 employees as of September 2024. These team members are located across 2 continents, including North AmericaEurope.

Who are Elicio Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of September 2024, Elicio Therapeutics's key employees include:

  • Chief Scientific Officer: P. C. D.
  • Chief Financial Officer: B. P.
  • Chief Business Officer: A. M.
  • Vice President Of Biometrics: H. H.
  • Executive Vice President, Head Of Research And Development, Chief Medical Officer: C. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.